(Corrects name of rare neurological disorder, to ATTRv-PN, in paragraph 9) By Maggie Fick LONDON, July 24 (Reuters) - ...

AstraZeneca shares suffered their biggest fall in 15 months on Thursday after the UK’s largest drugmaker said a heart ...

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

Shares in AstraZeneca fell 4% during the second quarter, and deepened their losses in July after the company said its Wainua drug failed to reduce deaths from a heart condition in a late-stage ...

A late-stage clinical trial failed to miss its primary endpoint, U.K.'s laregst drugmaker said Thursday.

Sino Biopharmaceutical will receive an upfront payment of $200m from AstraZeneca.

For years, AstraZeneca has commanded one of the richest valuations among large European pharma companies on the assumption that it consistently delivers results.

The approval opens a big market for camizestrant as U.S. regulators continue to review the company’s application there.

CHICAGO — AstraZeneca’s head of cancer research and development, Susan Galbraith, is British, and prone to a particularly British style of understatement. She doesn’t boast loudly. But she did come to ...

Sino Biopharmaceutical will receive $200 million upfront from AstraZeneca, and will be eligible for milestone payments.

Nearly a decade after spinning out its Chinese research hub to form Dizal Pharmaceutical, AstraZeneca is paying up to $1.5 billion to buy a piece of the pipeline, securing exclusive global rights for ...

LONDON (AP) — The pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled, according to the EU medicines regulator. In an update on the European ...